News & Updates
Showing Respirology articles
Showing

Novel EGFR inhibitor shows potential in REZILIENT 3
In the phase III REZILIENT* 3 trial, adding zipalertinib to chemotherapy improves progression-free survival (PFS) in patients with treatment-naïve metastatic non-small cell lung cancer (NSCLC) harbouring EGFR exon 20 insertion mutations (ex20ins-mut).

SUNRISE supports tezepelumab in severe OCS-dependent asthma
In the phase III SUNRISE trial, tezepelumab significantly reduces daily maintenance oral corticosteroid (OCS) dose while maintaining asthma control in adults with severe OCS-dependent asthma, despite early study termination and the smaller-than-planned sample size.

Acupuncture shows promise in management of asthma attack in ED
A small observational study involving patients presenting to the emergency department (ED) with an acute asthma attack has noted therapeutic benefits with adjunct acupuncture, resulting in fewer inpatient admissions and rapid improvement in peak expiratory flow rate (PEFR).

Baseline NLR predicts risk of severe CIP in patients with NSCLC
A high neutrophil-to-lymphocyte ratio (NLR; ≥4.75) at baseline appears to contribute to an elevated risk of developing severe checkpoint inhibitor pneumonitis (CIP) in patients with nonsmall cell lung cancer (NSCLC), suggests a study.




